tirzepatide central scottsdale CLINIC: ZEPBOUND & SEMAGLUTIDE WEIGHT LOSS SOLUTION Tirzepatide - Ward Dean, M.D.

AMP-1P AMP-1P Receptor Research Peptide FOR LABORATORY RESEARCH USE ONLY NOT FOR HUMAN OR VETERINARY CONSUMPTION

In clinical research studies, the most commonly investigated dosing regimen has been 500 mg taken two to three times daily , giving a total daily dose of 1,0001,500 mg

Some newer medications such as tirzepatide could offer more weight loss benefits since they work on two hormones (GLP-1 and GIP)

The platform may be worth evaluating for adults who: Prefer a fully online intake, provider review, and home delivery process for eligible prescription programs Are researching GLP-1-supported weight management and want a platform that names its physicians and pharmacy partners publicly Want FSA/HSA-eligible telehealth access across multiple health categories in a single platform Are members of or allies within the LGBTQ+ community and want care from a platform built with that community's needs as the primary design consideration Need Spanish-speaking provider availability Are comfortable with the no-refund structure and auto-renewal terms described above CareBareRX may not be the right fit for people who require in-person medical evaluation, have contraindications to the medications being considered (see safety disclosures above), need insurance to cover prescription costs, want a refund option if a prescription is not approved, or are not comfortable with auto-renewal billing and final-sale prescription terms

How GLP-1 Drugs Work Dual-agonist and single-agonist drugs stimulate hormones that help control blood sugar levels and reduce appetite, leading to weight loss

doi: 10.1111/cup.13775 79 BaetzTDFletcherGGKnightGMcWhirterERajagopalSSongXet al